SKYE BIOSCIENCE INC (SKYE) Forecast, Price Target & Analyst Ratings

NASDAQ:SKYEUS83086J2006

Current stock price

0.72 USD
-0.01 (-0.8%)
At close:
0.7254 USD
+0.01 (+0.75%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SKYE BIOSCIENCE INC (SKYE).

Forecast Snapshot

Consensus Price Target

Price Target
$8.89
+ 1,134.53% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.32
Revenue Estimate

ChartMill Buy Consensus

Rating
81.43%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.89
Upside
+ 1,134.53%
From current price of $0.72 to mean target of $8.89, Based on 14 analyst forecasts
Low
$2.02
Median
$10.20
High
$21.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for SKYE. The average price target is 8.89 USD. This implies a price increase of 1134.53% is expected in the next year compared to the current price of 0.72.

Analyst Ratings & History

Current Analyst Ratings

SKYE Current Analyst RatingSKYE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

SKYE Historical Analyst RatingsSKYE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
81.43%
SKYE was analyzed by 14 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about SKYE.
In the previous month the buy percentage consensus was at a similar level.
SKYE was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-09-30HC Wainwright & Co.Initiate Buy
2025-08-15Evercore ISI GroupInitiate Outperform
2025-06-24JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-03-21Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-03-21Craig-HallumMaintains Buy -> Buy
2025-02-28William BlairInitiate Outperform
2024-09-30ScotiaBankInitiate Sector Outperform
2024-09-20Cantor FitzgeraldReiterate Overweight -> Overweight
2024-09-20Piper SandlerReiterate Overweight -> Overweight
2024-09-10JMP SecuritiesInitiate Market Outperform
2024-09-09Cantor FitzgeraldReiterate Overweight -> Overweight
2024-09-06Cantor FitzgeraldReiterate Overweight -> Overweight
2024-08-27Cantor FitzgeraldReiterate Overweight -> Overweight
2024-07-09Craig-HallumInitiate Buy
2024-07-01Cantor FitzgeraldReiterate Overweight -> Overweight
2024-06-18Cantor FitzgeraldReiterate Overweight -> Overweight
2024-06-17Cantor FitzgeraldReiterate Overweight -> Overweight
2024-05-23Cantor FitzgeraldInitiate Overweight
2024-04-12OppenheimerInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.32
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-14.99%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.63%
EPS (3 Months)
0.63%

Next Earnings Summary

SKYE is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.32 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SKYE revenue by date.SKYE revenue by date.
N/AN/AN/AN/AN/AN/A
411.29%
N/A
83.87%
N/A
47.88%
EBITDA
YoY % growth
SKYE ebitda by date.SKYE ebitda by date.
-4.31M-4.46M
-3.48%
-3.85M
13.68%
-4.69M
-21.82%
-6.63M
-41.36%
-6.29M
5.13%
-7.82M
-24.32%
-11.99M
-53.32%
-34.763M
-189.93%
-36.129M
-3.93%
-57.44M
-58.99%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
SKYE ebit by date.SKYE ebit by date.
-4.32M-4.47M
-3.47%
-3.86M
13.65%
-4.69M
-21.50%
-6.63M
-41.36%
-6.29M
5.13%
-7.85M
-24.80%
-12.11M
-54.27%
-34.887M
-188.08%
-36.427M
-4.42%
-58.164M
-59.67%
N/A
15.83%
N/A
-34.78%
N/A
-42.62%
N/A
-49.25%
N/A
-22.50%
N/A
39.80%
N/A
71.81%
N/A
304.28%
Operating Margin
SKYE operating margin by date.SKYE operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SKYE eps by date.SKYE eps by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A-0.72
87.00%
-3.65
-406.94%
N/A
71.65%
N/A
-16.67%
N/A
-21.33%
N/A
-21.52%
N/A
-10.79%
N/A
44.82%
N/A
73.12%
N/A
269.76%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.32
-14.99%
-0.24
91.08%
-0.24
24.99%
-0.25
30.49%
-0.29
11.06%
-0.28
-18.32%
-0.28
-18.13%
-0.30
-19.23%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-12.719M
-8.16%
-12.689M
30.45%
-12.781M
3.65%
-13.178M
11.53%
-19.21M
-51.03%
-19.89M
-56.75%
-20.4M
-59.62%
-21.08M
-59.96%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SKYE Yearly Revenue VS EstimatesSKYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2030 2031 2032 2033 100M 200M 300M
SKYE Yearly EPS VS EstimatesSKYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.93%
EPS Next 5 Year
7.86%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

SKYE BIOSCIENCE INC / SKYE Forecast FAQ

What is the price target for SKYE stock?

14 analysts have analysed SKYE and the average price target is 8.89 USD. This implies a price increase of 1134.53% is expected in the next year compared to the current price of 0.72.

Can you provide the upcoming earnings date for SKYE BIOSCIENCE INC?

SKYE BIOSCIENCE INC (SKYE) will report earnings on 2026-05-06.

What are the consensus estimates for SKYE BIOSCIENCE INC (SKYE) next earnings?

The consensus EPS estimate for the next earnings of SKYE BIOSCIENCE INC (SKYE) is -0.32 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for SKYE stock?

The number of analysts covering SKYE BIOSCIENCE INC (SKYE) is 14.